This report provides a comprehensive analysis of current global Gut Microbiome market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Gut Microbiome industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to GRD Survey, the global Gut Microbiome market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Gut Microbiome Market Opportunities and Forecast 2023-2028 report makes a brilliant attempt to unveil key opportunities available in the global Gut Microbiome market under the Covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Gut Microbiome Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Gut Microbiome industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions

Segmented by Type
Obesity
Inflammatory Bowel Disease (IBD)
Diabetes
Others

Segmented by Application
Human
Animal

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in GRD Survey
Viome
ProDigest
Novome Biotechnologies
LNC Therapeutics
Kintai Therapeutics
Ixcela, Inc
Enterome BioScience
Carbiotix
Caelus Health
Assembly Biosciences
AnimalBiome

Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Gut Microbiome Market Status and Forecast (2017-2028)
1.3.2 Global Gut Microbiome Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Gut Microbiome Supply by Company
2.1 Global Gut Microbiome Sales Value by Company
2.2 Gut Microbiome Sales Area of Main Manufacturers
2.3 Trend of Concentration Rate
3 Global and Regional Gut Microbiome Market Status by Type
3.1 Gut Microbiome Type Introduction
3.1.1 Obesity
3.1.2 Inflammatory Bowel Disease (IBD)
3.1.3 Diabetes
3.1.4 Others
3.2 Global Gut Microbiome Market by Type
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Gut Microbiome Market Status by Application
4.1 Gut Microbiome Segment by Application
4.1.1 Human
4.1.2 Animal
4.2 Global Gut Microbiome Market by Application
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Gut Microbiome Market Status by Region
5.1 Global Gut Microbiome Market by Region
5.2 North America Gut Microbiome Market Status
5.3 Europe Gut Microbiome Market Status
5.4 Asia Pacific Gut Microbiome Market Status
5.5 Central & South America Gut Microbiome Market Status
5.6 Middle East & Africa Gut Microbiome Market Status
6 North America Gut Microbiome Market Status
6.1 North America Gut Microbiome Market by Country
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Gut Microbiome Market Status
7.1 Europe Gut Microbiome Market by Country
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Gut Microbiome Market Status
8.1 Asia Pacific Gut Microbiome Market by Country
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Gut Microbiome Market Status
9.1 Central & South America Gut Microbiome Market by Country
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Gut Microbiome Market Status
10.1 Middle East & Africa Gut Microbiome Market by Country
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Major Downstream Customers Analysis
11.1 Customer One Analysis
11.2 Customer Two Analysis
11.3 Customer Three Analysis
11.4 Customer Four Analysis
12 Global Gut Microbiome Market Forecast by Type and by Application
12.1 Global Gut Microbiome Sales Value Forecast (2023-2028)
12.2 Global Gut Microbiome Forecast by Type
12.3 Global Gut Microbiome Forecast by Application
13 Global Gut Microbiome Market Forecast by Region/Country
13.1 Global Gut Microbiome Market Forecast by Region (2023-2028)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Viome
14.1.1 Company Information
14.1.2 Gut Microbiome Product Introduction
14.1.3 Viome Gut Microbiome Sales Value, Gross Margin and Global Share (2020-2022)
14.1.4 SWOT Analysis
14.2 ProDigest
14.2.1 Company Information
14.2.2 Gut Microbiome Product Introduction
14.2.3 ProDigest Gut Microbiome Sales Value, Gross Margin and Global Share (2020-2022)
14.2.4 SWOT Analysis
14.3 Novome Biotechnologies
14.3.1 Company Information
14.3.2 Gut Microbiome Product Introduction
14.3.3 Novome Biotechnologies Gut Microbiome Sales Value, Gross Margin and Global Share (2020-2022)
14.3.4 SWOT Analysis
14.4 LNC Therapeutics
14.4.1 Company Information
14.4.2 Gut Microbiome Product Introduction
14.4.3 LNC Therapeutics Gut Microbiome Sales Value, Gross Margin and Global Share (2020-2022)
14.4.4 SWOT Analysis
14.5 Kintai Therapeutics
14.5.1 Company Information
14.5.2 Gut Microbiome Product Introduction
14.5.3 Kintai Therapeutics Gut Microbiome Sales Value, Gross Margin and Global Share (2020-2022)
14.5.4 SWOT Analysis
14.6 Ixcela, Inc
14.6.1 Company Information
14.6.2 Gut Microbiome Product Introduction
14.6.3 Ixcela, Inc Gut Microbiome Sales Value, Gross Margin and Global Share (2020-2022)
14.6.4 SWOT Analysis
14.7 Enterome BioScience
14.7.1 Company Information
14.7.2 Gut Microbiome Product Introduction
14.7.3 Enterome BioScience Gut Microbiome Sales Value, Gross Margin and Global Share (2020-2022)
14.7.4 SWOT Analysis
14.8 Carbiotix
14.8.1 Company Information
14.8.2 Gut Microbiome Product Introduction
14.8.3 Carbiotix Gut Microbiome Sales Value, Gross Margin and Global Share (2020-2022)
14.8.4 SWOT Analysis
14.9 Caelus Health
14.9.1 Company Information
14.9.2 Gut Microbiome Product Introduction
14.9.3 Caelus Health Gut Microbiome Sales Value, Gross Margin and Global Share (2020-2022)
14.9.4 SWOT Analysis
14.10 Assembly Biosciences
14.10.1 Company Information
14.10.2 Gut Microbiome Product Introduction
14.10.3 Assembly Biosciences Gut Microbiome Sales Value, Gross Margin and Global Share (2020-2022)
14.10.4 SWOT Analysis
14.11 AnimalBiome
15 Conclusion
16 Methodology